These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 6102877)

  • 41. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    Ozdogan H; Turunç M; Deringöl B; Yurdakul S; Yazici H
    J Rheumatol; 1986 Feb; 13(1):124-5. PubMed ID: 2871188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
    Boyd O; Gibbs AR; Smith AP
    Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulphasalazine: a 'new' antirheumatic drug.
    Pullar T; Capell HA
    Br J Rheumatol; 1984 Feb; 23(1):26-34. PubMed ID: 6141832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leucopenia in rheumatoid arthritis: relationship to gold or sulphasalazine therapy.
    Amos RS; Bax DE
    Br J Rheumatol; 1988 Dec; 27(6):465-8. PubMed ID: 2904830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.
    Amos RS; Crockson RA; Crockson AP; Walsh L; McConkey B
    Br Med J; 1978 May; 1(6124):1396. PubMed ID: 647307
    [No Abstract]   [Full Text] [Related]  

  • 55. Macrocytosis and sulphasalazine treatment of rheumatoid arthritis.
    Ralston SH; Willocks LJ; Shaw RW; Pitkeathly DA
    Br J Rheumatol; 1987 Dec; 26(6):472-3. PubMed ID: 2891393
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial.
    Capell HA; Madhok R; Hunter JA; Porter D; Morrison E; Larkin J; Thomson EA; Hampson R; Poon FW
    Ann Rheum Dis; 2004 Jul; 63(7):797-803. PubMed ID: 15194574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulphasalazine and regression of rheumatoid nodules.
    Englert HJ; Hughes GR; Walport MJ
    Ann Rheum Dis; 1987 Mar; 46(3):244-5. PubMed ID: 2883940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1985 Dec; 44(12):831-7. PubMed ID: 2867746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.